Phreesia (NYSE:PHR) Receives Sector Perform Rating from Royal Bank of Canada

Phreesia (NYSE:PHR)‘s stock had its “sector perform” rating reissued by investment analysts at Royal Bank of Canada in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $23.00 price objective on the stock. Royal Bank of Canada’s price target points to a potential upside of 1.41% from the stock’s current price.

Several other research analysts also recently commented on PHR. Canaccord Genuity Group reiterated a “buy” rating and issued a $34.00 price objective on shares of Phreesia in a report on Thursday, September 5th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research report on Thursday, September 5th. DA Davidson reissued a “buy” rating and issued a $32.00 price target on shares of Phreesia in a research report on Thursday, September 5th. Finally, KeyCorp dropped their price target on Phreesia from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Thursday, July 11th. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $29.42.

Phreesia Price Performance

NYSE PHR traded up $0.48 during trading hours on Friday, reaching $22.68. 24,638 shares of the stock traded hands, compared to its average volume of 462,280. The stock has a 50 day simple moving average of $24.03 and a two-hundred day simple moving average of $22.65. Phreesia has a 1 year low of $12.05 and a 1 year high of $29.16. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77. The company has a market cap of $1.31 billion, a price-to-earnings ratio of -10.38 and a beta of 0.93.

Insider Transactions at Phreesia

In related news, General Counsel Allison C. Hoffman sold 14,110 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $26.03, for a total transaction of $367,283.30. Following the completion of the transaction, the general counsel now owns 121,003 shares of the company’s stock, valued at $3,149,708.09. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, SVP David Linetsky sold 1,820 shares of the company’s stock in a transaction dated Tuesday, July 16th. The shares were sold at an average price of $23.74, for a total transaction of $43,206.80. Following the completion of the sale, the senior vice president now owns 202,218 shares of the company’s stock, valued at approximately $4,800,655.32. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, General Counsel Allison C. Hoffman sold 14,110 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $26.03, for a total transaction of $367,283.30. Following the sale, the general counsel now directly owns 121,003 shares of the company’s stock, valued at approximately $3,149,708.09. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 46,203 shares of company stock worth $1,129,699. Company insiders own 5.80% of the company’s stock.

Institutional Trading of Phreesia

Hedge funds have recently made changes to their positions in the company. Ensign Peak Advisors Inc lifted its holdings in Phreesia by 3.2% during the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after buying an additional 700 shares in the last quarter. Conestoga Capital Advisors LLC grew its position in Phreesia by 1.0% during the 1st quarter. Conestoga Capital Advisors LLC now owns 78,085 shares of the company’s stock worth $1,869,000 after purchasing an additional 750 shares during the last quarter. ProShare Advisors LLC boosted its holdings in shares of Phreesia by 8.6% in the first quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock valued at $228,000 after acquiring an additional 751 shares in the last quarter. Rhumbline Advisers boosted its holdings in shares of Phreesia by 1.0% in the second quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock valued at $1,741,000 after acquiring an additional 853 shares in the last quarter. Finally, Swiss National Bank lifted its stake in shares of Phreesia by 1.0% in the first quarter. Swiss National Bank now owns 104,300 shares of the company’s stock valued at $2,496,000 after purchasing an additional 1,000 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.